Effect of Olmesartan Medoxomil on Atherosclerosis: Clinical Implications of the Emerging Evidence

Author： Takai Shinji   Miyazaki Mizuo  

Publisher： Adis International

ISSN： 1175-3277

Source： American Journal of Cardiovascular Drugs, Vol.6, Iss.6, 2006-01, pp. : 363-366

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Olmesartan medoxomil: recent clinical and experimental acquisitions

By Destro Maurizio   Preti Paola   D'Ospina Antonio   Christian Achiri Ngu Njwe   Ricci Alessandra Rossi   Cagnoni Francesca  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 5, Iss. 9, 2009-09 ,pp. : 1149-1157

Informa Healthcare

Access to resources Recommend Favorite

Olmesartan Medoxomil

By Warner G.T.   Jarvis B.  

Drugs, Vol. 62, Iss. 9, 2002-01 ,pp. : 1345-1353

Adis International

Access to resources Recommend Favorite

Olmesartan medoxomil beneficial in hypertension

By  

Inpharma, Vol. 1, Iss. 1639, 2008-01 ,pp. : 17-17

Adis International

Access to resources Recommend Favorite

Olmesartan Medoxomil/Amlodipine

By Sanford Mark   Keam Susan J.  

Drugs, Vol. 69, Iss. 6, 2009-01 ,pp. : 717-729

Adis International

Access to resources Recommend Favorite

Olmesartan medoxomil/HCTZ beneficial in hypertension

By  

Inpharma, Vol. 1, Iss. 1539, 2006-01 ,pp. : 19-19

Adis International

Access to resources Recommend Favorite